Shanghai Fosun Pharmaceutical (Group) Co (SHSE:600196) EBITDA Margin % : 14.39% (As of Dec. 2024)

View and export this data going back to 1998. Start your Free Trial

What is Shanghai Fosun Pharmaceutical (Group) Co EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Shanghai Fosun Pharmaceutical (Group) Co's EBITDA for the three months ended in Dec. 2024 was ¥1,462 Mil. Shanghai Fosun Pharmaceutical (Group) Co's Revenue for the three months ended in Dec. 2024 was ¥10,155 Mil. Therefore, Shanghai Fosun Pharmaceutical (Group) Co's EBITDA margin for the quarter that ended in Dec. 2024 was 14.39%.

Shanghai Fosun Pharmaceutical (Group) Co EBITDA Margin % Historical Data

The historical data trend for Shanghai Fosun Pharmaceutical (Group) Co's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Fosun Pharmaceutical (Group) Co EBITDA Margin % Chart

Shanghai Fosun Pharmaceutical (Group) Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EBITDA Margin %

Get a 7-Day Free Trial

23.84

22.30

17.92

18.25

20.95

Shanghai Fosun Pharmaceutical (Group) Co Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
EBITDA Margin %	Get a 7-Day Free Trial															3.26	13.45	12.36	14.34	14.39

Competitive Comparison of Shanghai Fosun Pharmaceutical (Group) Co's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Shanghai Fosun Pharmaceutical (Group) Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shanghai Fosun Pharmaceutical (Group) Co's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shanghai Fosun Pharmaceutical (Group) Co's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Shanghai Fosun Pharmaceutical (Group) Co's EBITDA Margin % falls into.

Save Embed

;

Save Embed

;

Shanghai Fosun Pharmaceutical (Group) Co EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Shanghai Fosun Pharmaceutical (Group) Co's EBITDA Margin % for the fiscal year that ended in Dec. 2024 is calculated as

EBITDA Margin %	=	EBITDA (A: Dec. 2024 )	/	Revenue (A: Dec. 2024 )
	=	8602.739	/	41067.196
	=	20.95 %

Shanghai Fosun Pharmaceutical (Group) Co's EBITDA Margin % for the quarter that ended in Dec. 2024 is calculated as

EBITDA Margin %	=	EBITDA (Q: Dec. 2024 )	/	Revenue (Q: Dec. 2024 )
	=	1461.754	/	10155.307
	=	14.39 %

Shanghai Fosun Pharmaceutical (Group) Co (SHSE:600196) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Shanghai Fosun Pharmaceutical (Group) Co EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Shanghai Fosun Pharmaceutical (Group) Co's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Fosun Pharmaceutical (Group) Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196) » Definitions » EBITDA Margin %

Traded in Other Exchanges

SFOSF:USA 02196:Hong Kong 08HH:Germany

Address

No. 1289 Yishan Road, Building A, Fosun Technology Park, Shanghai, CHN, 200233

Website

https://www.fosunpharma.com

Shanghai Fosun Pharmaceutical (Group) Co Ltd is engaged in the development, manufacture, and sale of pharmaceutical products and medical equipment, the import and export of medical equipment, and the provision of related and other consulting services and investment management. Its business segments are Pharmaceutical manufacturing, Healthcare Services, Medical devices, and medical diagnosis. It generates the majority of its revenue from the Pharmaceutical manufacturing segment. The company considers merger and acquisition investment as a potential component of its operational growth for expanding its research, development, manufacturing, and marketing capabilities. Its geographic areas are the Chinese mainland, Regions outside the Chinese mainland, and other countries.

Executives

Yao Fang	Director
Wu Yi Fang	Director
Wen De Yong	Directors, senior managers
Guan Xiao Hui	Director
Wang Ke Xin	Director
Bao Qin Gui	senior management
Mei Jing Ping	senior management
Li Sheng Li	senior management
Feng Rong Li	senior management
Wang Dong Hua	senior management
Dong Xiao Xian	senior management
Su Li	senior management
Zhu Yue	senior management
Chen Yu Qing	senior management
Hu Hang	senior management

Shanghai Fosun Pharmaceutical (Group) Co Headlines

No Headlines